Benchmark Studies


Email LinkedIn Twitter

The benchmark studies below are part of Best Practices, LLC's ongoing Research and Consulting initiatives. By participating in one of the following surveys, you will receive a free copy of the results in presentation format. All benchmark study results are blinded and aggregated to ensure confidentiality.

You can access free excerpts of previous studies archived under
Benchmarking Reports and Best Practice Database.

Current Benchmark Studies Subscribe to our RSS Feed of Current Surveys

  • Developing World-Class Regulatory Systems That Lead to Successful NDAs and Optimize FDA Working Relationships
  • Survey Topic: Developing World-Class Regulatory Systems That Lead to Successful NDAs and Optimize FDA Working Relationships


    Objective: Bringing New Drug Applications (NDA) through the Food and Drug Administration (FDA) approval process is the gateway to commercial success. However, increasing safety concerns, market and political pressures, make this NDA approval process more difficult than ever.

    Those companies that develop effective systems to work with the FDA enjoy a critical advantage in the commercialization process.

    This biopharmaceutical benchmarking study is designed to gain insights into how pharmaceutical companies successfully interact with employees of the Food and Drug Administration during the NDA process.


    Lead Researcher: Cameron Tew

    Invited Participants: Executives that oversee, manage and direct functions that interact with the Food and Drug Administration during the New Drug Application process.

    Survey Contact Contact: To participate in this survey, please contact Cameron Tew at (919)-767-9246 or ctew@best-in-class.com

    Participate in this Survey



  • Thought Leader Fair Market Value - 2016
  • Survey Topic: Thought Leader Fair Market Value - 2016


    Objective: With increasing importance of transparency, healthcare leaders must provide a clear line of sight into how they compensate industry thought leaders and physicians. Bio-pharma executives are being pressed to re-assess their current thought leader compensation strategies as new state reporting laws and changes to their organizations’ policies (PhRMA code, ACCME guidelines, etc.) are being enforced. At the same time, access to thought leaders themselves has continued to shrink, whether in academic institutions or elsewhere.

    Put simply, it has never been more important for healthcare companies to get it right when it comes to thought leader management. This benchmarking study is designed to examine trends in Fair Market Value for thought leaders, capturing critical metrics and insights on thought leader management, compensation levels, and proven practices.

    Lead Researcher: Cameron Tew

    Invited Participants: Vice presidents, executives, directors, managers, and other professionals working within Medical Affairs and thought leader management functions.

    Time Commitment: Approximately Time25-30 minutes

    Survey Contact Contact: To participate in this survey, please contact Cameron Tew at (919)-767-9246 or ctew@best-in-class.com.  

    Participate in this Survey




  • NEW 2016 - Winning the Necessary Resources for a Successful Product Launch
  • Survey Topic: NEW 2016 - Winning the Necessary Resources for a Successful Product Launch


    Objective: Pharmaceutical companies can no longer afford to rely solely on past experience when budgeting for a new product launch in today's fast-changing, highly competitive market. This comprehensive benchmark study investigates current costs as well as budget and staffing allocations required for a successful drug launch.Pharmaceutical leaders who participate in this study can use the resulting benchmark data to determine whether their own investment levels for promotional, educational, market access, Medical Affairs, and other launch-related activities are competitive in the new marketplace.

    Lead Researcher: Cameron Tew

    Invited Participants: Pharma and biotech executives, directors, managers, and brand team leaders who have recent or current experience with the launch (or launch preparation) of a new pharmaceutical product.

    Survey Contact Contact: To participate in this survey, please contact Cameron Tew, Head of Research, at (919)-767-9246 or ctew@best-in-class.com.

    Participate in this Survey

      



    Benchmark Studies


    Contact Info CONTACT PERSON
    -----------------------------------------

    Scott Brown, Ph.D,
    Executive Director of Global Research Operations and Consulting Services

    Phone: (919) 767-9164

    Email Email Scott Brown


     
    ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE
    Quick Links  Product RSS Feed
    Payment gateway
    Secured by PayPal

    Follow Us: 

    linkedin twitter slideshare youtube google + pinterest

    All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
    Read our Terms and Conditions of Use, Privacy Policy and Copyright Information